NCT07870395Recruiting
Voice-based Outcome Identification and Clinical Evaluation in Heart Failure
Source: ClinicalTrials.gov · Last updated 27 Oct 2026
Brief summary (registry, in English)
VOICE-HF is a clinical study designed to evaluate the performance of a novel non-invasive software device (Noah Labs Vox) that uses vocal characteristics to estimate DHF risk and has strong potential for clinical success. This study will compare the performance of Noah Labs Vox with the contemporary performance of commonly used weight-based remote monitoring rules and applications to determine efficacy and safety.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 450 (estimated)
- First submitted
- 6 Oct 2026
- Start date
- 15 Oct 2026
- Primary completion date
- Dec 2027
- Lead sponsor
- Noah Labs
- Diseases
- Heart failure
- NCT number
- NCT07870395
What you commit to
- Study type: Observational
- Planned participants: 450
- From 15 Oct 2026 to the primary completion date, Dec 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Planned cardiac surgery or major intervention (e.g., LVAD or transplant), or
Other
- Monitoring with implantable volume or pressure monitoring devices, or
- Otherwise inability or unwillingness to comply with study procedures.
Who the study is looking for
- Age ≥22
- HF diagnosis (Stage C)
- DHF event within prior 180 days
Age in the registry: 22 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Brigham and Women's Hospital Coordinator of this site? Confirm its status | Boston | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.